Is Your Bacteria Friendly?

September 5, 2008 – 9:34 pm

Welcome back!

Colonies of “friendly” bacteria must live in the colon for it to function properly. Without these beneficial bacteria, we are more susceptible to harmful yeasts, intestinal toxemia, dangerous bacteria, viruses, and a wide spectrum of other problems. Why? Because without the good bacteria to eat up the toxic waste from food that has not been completely digested and eliminated, the inner walls of the colon can become encrusted with layers of putrefying waste.

Over the course of decades, this layered waste can become thick and hard, forming a barrier that prevents vital nutrients from passing through the walls and being fully absorbed by the organs and systems that need these nutrients to do their jobs.  With the presence of this decaying waste, the colon can become a breeding ground for numerous harmful bacteria, yeasts, viruses, and more.  The added toxins produced by these unwelcome invaders can spread throughout your body, literally poisoning you.

Your “starved” and poisoned organs and systems can become stressed and eventually weaken to the point where they fail to function properly. This is why so many researchers now believe that “death begins in the colon.”

Unfortunately, the that should populate our colons and prevent this sort of scenario are constantly under attack by an increasingly diverse array of enemies. These include the all-too-common enemies of chlorinated water, the antibiotics we take for illness and those we ingest in the meat and pasteurized dairy products we consume, alcoholic beverages, some chemicals, as well as radiation and chemotherapy.

These “friendly” intestinal bacteria used to be passed naturally from mother to infant. Unfortunately, over the past half-century, in our haste to kill all bacteria, we have also killed the good with the bad. And unless we have consciously reintroduced good bacteria into our intestinal tracts, most of us no longer have these good bacteria working for us.

Health Benefits
These good bacteria are called “Probiotic”.  The first three letters, “Pro”, mean for and the balance of the word— “Biotic”, means life.  So a is for life, or pro-life.  These important work primarily in the large intestine, but are present in the rest of the digestive tract as well.  Basically, there are two groups of naturally occurring micro-organisms functioning in the digestive system. The first group is considered beneficial or non-pathogenic, and is actually made up of several hundred different kinds of . The second group is the potentially pathogenic group, including again hundreds of possible bad guys like and .

work by competitive exclusion. This means that the greater number of different species of friendly-intestinal bacteria that are present in the probiotic compound, the harder it is for the competing bad bacteria and yeasts to get started. The good bacteria clean out the intestinal tract of waste products from food as well as drive out the bad bacteria. This, of course, leads to better and utilization of the food we eat and elimination of pockets of bad bacteria, that are present in many people’s intestines, thus contributing significantly to overall good health.  It is estimated that over 400 species of bacteria inhibit the human digestive tract.

Scientific Studies
In a report in the Annals of Internal Medicine, March 1992, 33 women participated in a study conducted at the Long Island Jewish Medical Center.  The women each had recurrent candidal vaginitis and were given eight ounces of yogurt containing .  The study called for the women to consume the yogurt for six months and then refrain from any yogurt for six months.  The thirteen women that completed the study saw a significant decline in vaginal candidal infections while they consumed yogurt (.38 infections during yogurt consumption versus 2.54 in the later six months).  The results suggest that the daily consumption of eight ounces of yogurt with decreases both candidal colonization and infection.

In 1996, a review of controlled studies done on probiotics between 1966 and 1995 was published in the Journal of American Medical Association.  The conclusion from these studies was that , L. bulgaricus, and B. bifidum were effective for treating antibiotic-associated diarrhea (ADD) and vaginal yeast infections.  In one study, 79 people receiving the antibiotic ampicillin were split into two groups.  Thirty-six received a mixture of and L. bulgaricus and none developed ADD by the end of the study.  Six of the forty-three people in the placebo group did develop ADD.

Many modern researchers have found that are very important for maintaining intestinal balance.  At a European symposium on probiotics, scientists from several countries reviewed studies on the benefits of probiotics.  For example, Finnish researchers reported from their research that good bacteria helped strengthen the immune system and helped stabilized the intestines.  They felt that probiotics were a viable option for addressing such problems as food allergies, diarrhea, inflammatory bowel disease, gastroenteritis, and lactose intolerance.  German experts, based on the results of nearly 70 studies, concluded that probiotics were helpful for treating colon problems.  Danish nutrition experts found that probiotics were effective for supporting the immune system and helping with blood related issues.

The August issue of Gastroenterology reported on the findings of a double blind, placebo-controlled study that examined the benefits of using probiotics in the treatment of chronic intestinal inflammation.  In this study forty patients with chronic pouchitis, an inflammation of the small intestine, were randomly divided into two groups.  Pouchitis appears to be tied to lower levels of some bacteria in the intestinal tract.  Twenty patients received a probiotic preparation consisting of four strains of lactobacilli, three strains of bifidobacteria, and one strain of streptococcus salivarius subspecies thermophilus.  The other group of twenty patients received a placebo.  During the nine-month treatment phase, 85 percent of the patients in the probiotic group remained free of pouchitis symptoms.  All 20 patients in the placebo group experienced recurring symptoms.  In the probiotic group, the benefits of the probiotics lasted ceased within four months after the study ended.  The conclusion of the researchers was that the study validated the clinical effectiveness of probiotics in the treatment of chronic intestinal inflammation and that long-term use was safe.

To find out more how probiotics can help you, check out Powerful Probiotic

References:
Hilton Eileen, et al. “Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis.” Annals Internal Medicine (116 (5), pages 353-357): Pennsylannia; March 1992.
Elmer G. W., Surawicz C. M., McFarland L. V. “Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.” Journal of American Medical Association (275: 870 – 876): Illinois; March 1996.
Moneysmith Marie, “Lactobacillus acidophilus? – Beneficial bacteria and probiotic supplements in treatment of digestive conditions.” Better Nutrition. Primedia Intertec: Illinois; 2001.

Resources:
Brudnak Mark A. “The Probiotic Solution: Nature’s Best-Kept Secret for Radiant Health.” Dragon Door Publications: Minnesota; 2003.
Rdemond Cheryl, “Make friends with good bacteria: if bad bacteria are ruling your digestive system, you could be setting yourself up for health problems – Do-It-Yourself Cures.” Natural Health. Weider Publications: New York; March 2002.
Sharma A., Mohan P., Nayak B., “Probiotics: Making a Comeback.” Indian Journal of Pharmacology. Medknow Publications: India; Nov-Dec 2005.
Trenev Natasha, “Probiotics: Nature’s Internal Healers.” Avery Publishing Group: New York; 1998.
Gastroenterology  08/01/2000 (Volume 119, Number 2)
Gionchetti P, Rizzello F, Venturi A, et al. “Oral Bacteriotherapy as Maintenance Treatment in Patients With Chronic Pouchitis: A Double-Blind, Placebo-Controlled Trial.” Gastroenterology (119(2):305-309); August 2000.
Tetsuji Hori, Junko Kiyoshima, Kan Shida, and Hisako Yasui. “Effect of Intranasal Administration of Lactobacillus casei Shirota on Influenza Virus Infection of Upper Respiratory Tract in Mice.” Clinical and Diagnostic Laboratory Immunology (8:593-597): American Society for Microbiology: Washington, D.C.; May 2001.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google

Technorati Tags: , , , , ,

If you enjoyed this post, make sure you subscribe to my RSS feed!

Post a Comment